SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-016272
Filing Date
2022-12-08
Accepted
2022-12-08 17:28:21
Documents
15
Period of Report
2022-12-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra_8k.htm   iXBRL 8-K 27213
2 CERTIFICATE endra_ex31.htm EX-3.1 6557
  Complete submission text file 0001654954-22-016272.txt   166701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20221208.xsd EX-101.SCH 5735
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20221208_lab.xml EX-101.LAB 15760
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20221208_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20221208_pre.xml EX-101.PRE 10015
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20221208_def.xml EX-101.DEF 2109
9 EXTRACTED XBRL INSTANCE DOCUMENT endra_8k_htm.xml XML 3827
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 221453256
SIC: 3845 Electromedical & Electrotherapeutic Apparatus